ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
S

ASCO 2022 on Overall Survival by IDH2 Mutant Allele (R140 or R172) in Late-Stage Mutant-IDH2 R/R AML Treated With Enasidenib or Conventional Care Regimens in the Phase 3 IDHENTIFY Trial

By ASCO 2022 Conference Coverage FEATURING Stéphane De Botton
By ASCO 2022 Conference Coverage FEATURING Stéphane De Botton
19 views
July 9, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Leukemia
47

Lecture Summary - ASCO 2022 Efficacy & Safety Results From the Phase…

ASCO 2022 Conference Coverage

J. Cortés

22 views
11:45

ASCO 2022 Efficacy & Safety Results From the Phase 3 ASCEMBL Study o…

ASCO 2022 Conference Coverage

J. Cortés

269 views
02:16

Lecture Summary - ASCO 2022 on Overall Survival by IDH2 Mutant Allel…

ASCO 2022 Conference Coverage

S. De Botton

13 views
08:40

ASCO 2022 on Overall Survival by IDH2 Mutant Allele (R140 or R172) i…

ASCO 2022 Conference Coverage

S. De Botton

19 views
07:21

ASCO 2022 Updated Results From a Phase II Study of mini-HCVD + Ino +…

ASCO 2022 Conference Coverage

W. Macaron

76 views
06:33

ASCO 2022 Treatment-Free Remission in CML Patients Following the Dis…

ASCO 2022 Conference Coverage

F. Haddad

143 views
36

Lecture Summary - ASCO 2022 Treatment-Free Remission in CML Patients…

ASCO 2022 Conference Coverage

F. Haddad

13 views
56

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase…

ASCO 2022 Conference Coverage

R. Cassaday

20 views
06:42

ASCO 2022 Updates on the Evolution of Asparaginase in the Management…

ASCO 2022 Conference Coverage

R. Cassaday

359 views
01:53

Lecture Summary - ASCO 2022 on Leveraging AML Genomics Across the Th…

ASCO 2022 Conference Coverage

G. Mannis

12 views
03:47

ASCO 2022 on a Phase 1b Study of Blinatumomab With the Anti-Programm…

ASCO 2022 Conference Coverage

C. Papayannidis

15 views
55

Lecture Summary - ASCO 2022 on a Phase 1b Study of Blinatumomab With…

ASCO 2022 Conference Coverage

C. Papayannidis

9 views
06:50

ASCO 2022 on a Phase II Study of Hyper-CVAD With Sequential Blina +/…

ASCO 2022 Conference Coverage

N. Short

25 views
01:09

Lecture Summary - ASCO 2022 on a Phase II Study of Hyper-CVAD With S…

ASCO 2022 Conference Coverage

N. Short

14 views
03:56

ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver,…

ASCO 2022 Conference Coverage

J. Cortés

83 views
36

Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastro…

ASCO 2022 Conference Coverage

J. Cortés

13 views
06:30

ASCO 2022 Efficacy and Safety of Bosutinib in Later-Line Patients Wi…

ASCO 2022 Conference Coverage

C. Gambacorti-Passerini

50 views